ID

13508

Description

Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML) https://clinicaltrials.gov/ct2/show/NCT01361334 Principal Investigator: PD Dr. Torsten Kessler, University Hospital Muenster, Germany

Link

https://clinicaltrials.gov/ct2/show/NCT01361334

Keywords

Versions (3)
  1. 8/14/15 8/14/15 - Martin Dugas
  2. 1/6/16 1/6/16 -
  3. 2/11/16 2/11/16 -
Uploaded on

February 11, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

End of study AML Pazopanib NCT01361334

German English

End of study AML Pazopanib NCT01361334

1 forms  
End of Study
Description

End of Study

Alias
UMLS CUI-1
C1518546
Patient ID (derived)
Description

Patient ID (derived)

Data type

text

Alias
UMLS CUI [1]
C2348585
End of study: date
Description

Studienabbruch: Datum

Data type

date

Alias
UMLS CUI [1]
C2985813
End of study: date of status
Description

Studienabbruch: Datum Status

Data type

text

Alias
UMLS CUI [1]
C2985875
End of study: withdrawal of informed consent
Description

Studienabbruch: Widerruf der Einwilligung

Data type

text

Alias
UMLS CUI [1]
C0021430
End of study: Violation of eligibility criteria
Description

Studienabbruch: Verletzte Ein-Ausschlusskrit.

Data type

text

Alias
UMLS CUI [1]
C1516637
End of study: adverse event
Description

Adverse event

Data type

text

Alias
UMLS CUI [1]
C0877248
Death
Description

Death

Data type

text

Alias
UMLS CUI [1]
C0011065
End of study: lost to follow up
Description

Studienabbruch: Lost to follow up

Data type

text

Alias
UMLS CUI [1]
C1302313
End of study: progressive disease
Description

Studienabbruch: Progression

Data type

text

Alias
UMLS CUI [1]
C1335499
End of study: relapse
Description

Studienabbruch: Rezidiv

Data type

text

Alias
UMLS CUI [1]
C0035020
End of study: new anti-leukemic treatment date
Description

Studienabbruch: Neue anti-leuk Ther - Datum

Data type

date

Alias
UMLS CUI [1,1]
C1299575
UMLS CUI [1,2]
C0011008
End of study: new anti-leukemic treatment date status
Description

Studienabbruch: Neue anti-leuk Ther - Datum Status

Data type

text

End of study: treatment modification, new antileukemic treatment
Description

Studienabbruch: Neue anti-leukäm. Therapie - Text

Data type

text

Alias
UMLS CUI [1]
C1299575
End of study: other reason
Description

Studienabbruch: Anderer Gund

Data type

text

Alias
UMLS CUI [1]
C0205394
End of study: other reason - text
Description

Studienabbruch: Anderer Gund - Text

Data type

text

End of study: complete remission
Description

Studienabbruch: Komplette Remission (CR)

Data type

text

Alias
UMLS CUI [1]
C0677874
End of study: CR(p)
Description

Studienabbruch: Komplette Remission (CRp)

Data type

text

Alias
UMLS CUI [1]
C3890735
End of study: CR(i)
Description

Studienabbruch: Komplette Remission (CRi)

Data type

text

Alias
UMLS CUI [1]
C3538993
End of study: PR
Description

Studienabbruch: Partielle Remission (PR)

Data type

text

Alias
UMLS CUI [1]
C1521726
End of study: Stable disease
Description

Studienabbruch: Stabile Erkrankung

Data type

text

Alias
UMLS CUI [1]
C0677946
End of study: progressive disease
Description

Studienabbruch: Progression

Data type

text

Alias
UMLS CUI [1]
C1335499
End of study: relapse
Description

Studienabbruch: Rezidiv

Data type

text

Alias
UMLS CUI [1]
C0035020
End of study: reason unknown
Description

Studienabbruch: Unbekannt

Data type

text

Alias
UMLS CUI [1]
C0439673
End of study: other
Description

Studienabbruch: Sonstiges

Data type

text

Alias
UMLS CUI [1]
C0205394
End of study: other (Text)
Description

Studienabbruch: Sonstiges - Text

Data type

text

End of study: signature date
Description

Studienabbruch: Signatur - Datum

Data type

date

Alias
UMLS CUI [1]
C0807937
End of study: signature - date status
Description

Studienabbruch: Signatur - Datum Status

Data type

text

Alias
UMLS CUI [1]
C2985875
End of study: signature of investigator
Description

Studienabbruch: Signatur - Prüfer

Data type

text

Alias
UMLS CUI [1]
C2346576
End of study: comment
Description

Kommentar Studienabbruch

Data type

text

Alias
UMLS CUI [1]
C0947611
End of study: violated inclusion/exclusion criteria
Description

End of study: violated inclusion/exclusion criteria

Alias
UMLS CUI-1
C1518546
UMLS CUI-2
C1516637
End of study: violated inclusion/exclusion criteria Code
Description

Studienabbruch: Verletzte Ein-Ausschlusskrit. Code

Data type

text

Alias
UMLS CUI [1,1]
C1518546
UMLS CUI [1,2]
C1516637
End of study: adverse event(s)
Description

End of study: adverse event(s)

Alias
UMLS CUI-1
C1518546
UMLS CUI-2
C0877248
End of study: adverse event(s) Nr
Description

Studienabbruch: Unerwünschte(s) Ereignis(se)-AE-Nr

Data type

integer

Alias
UMLS CUI [1,1]
C1518546
UMLS CUI [1,2]
C0877248
Back to the top of the page

Similar models

End of study AML Pazopanib NCT01361334

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
End of Study
C1518546 (UMLS CUI-1)
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Studienabbruch: Datum
Item
End of study: date
date
C2985813 (UMLS CUI [1])
Item
End of study: date of status
text
C2985875 (UMLS CUI [1])
Studienabbruch: Datum Status
Code List
End of study: date of status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Item
End of study: withdrawal of informed consent
text
C0021430 (UMLS CUI [1])
Studienabbruch: Widerruf der Einwilligung
Code List
End of study: withdrawal of informed consent
CL Item
End of study: withdrawal of informed consent through patient of legal representative (1)
Item
End of study: Violation of eligibility criteria
text
C1516637 (UMLS CUI [1])
Studienabbruch: Verletzte Ein-Ausschlusskrit.
Code List
End of study: Violation of eligibility criteria
CL Item
nachträgliche Feststellung durch den Prüfarzt, dass Einschlusskriterien nicht erfüllt sind ... (1)
Item
End of study: adverse event
text
C0877248 (UMLS CUI [1])
Studienabbruch: Unerwünschte(s) Ereignis(se)
Code List
End of study: adverse event
CL Item
adverse event(s) (1)
Item
Death
text
C0011065 (UMLS CUI [1])
Studienabbruch: Tod
Code List
Death
CL Item
Death (1)
Item
End of study: lost to follow up
text
C1302313 (UMLS CUI [1])
Studienabbruch: Lost to follow up
Code List
End of study: lost to follow up
CL Item
lost to follow up (1)
Item
End of study: progressive disease
text
C1335499 (UMLS CUI [1])
Studienabbruch: Progression
Code List
End of study: progressive disease
CL Item
progressive disease (1)
Item
End of study: relapse
text
C0035020 (UMLS CUI [1])
Studienabbruch: Rezidiv
Code List
End of study: relapse
CL Item
relapse (1)
Studienabbruch: Neue anti-leuk Ther - Datum
Item
End of study: new anti-leukemic treatment date
date
C1299575 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
End of study: new anti-leukemic treatment date status
text
Studienabbruch: Neue anti-leuk Ther - Datum Status
Code List
End of study: new anti-leukemic treatment date status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Studienabbruch: Neue anti-leukäm. Therapie - Text
Item
End of study: treatment modification, new antileukemic treatment
text
C1299575 (UMLS CUI [1])
Item
End of study: other reason
text
C0205394 (UMLS CUI [1])
Studienabbruch: Anderer Gund
Code List
End of study: other reason
CL Item
other reason (9)
Studienabbruch: Anderer Gund - Text
Item
End of study: other reason - text
text
Item
End of study: complete remission
text
C0677874 (UMLS CUI [1])
Studienabbruch: Komplette Remission (CR)
Code List
End of study: complete remission
CL Item
CR (1)
Item
End of study: CR(p)
text
C3890735 (UMLS CUI [1])
Studienabbruch: Komplette Remission (CRp)
Code List
End of study: CR(p)
CL Item
Complete remission with incomplete platelet recovery (1)
Item
End of study: CR(i)
text
C3538993 (UMLS CUI [1])
Studienabbruch: Komplette Remission (CRi)
Code List
End of study: CR(i)
CL Item
Complete response with incomplete bone marrow recovery (1)
Item
End of study: PR
text
C1521726 (UMLS CUI [1])
Studienabbruch: Partielle Remission (PR)
Code List
End of study: PR
CL Item
Partial remission (PR) (1)
Item
End of study: Stable disease
text
C0677946 (UMLS CUI [1])
Studienabbruch: Stabile Erkrankung
Code List
End of study: Stable disease
CL Item
Stable disease (1)
Item
End of study: progressive disease
text
C1335499 (UMLS CUI [1])
Studienabbruch: Progression
Code List
End of study: progressive disease
CL Item
Progression (1)
Item
End of study: relapse
text
C0035020 (UMLS CUI [1])
Studienabbruch: Rezidiv
Code List
End of study: relapse
CL Item
relapse (1)
Item
End of study: reason unknown
text
C0439673 (UMLS CUI [1])
Studienabbruch: Unbekannt
Code List
End of study: reason unknown
CL Item
unknown (9)
Item
End of study: other
text
C0205394 (UMLS CUI [1])
Studienabbruch: Sonstiges
Code List
End of study: other
CL Item
other (9)
Studienabbruch: Sonstiges - Text
Item
End of study: other (Text)
text
Studienabbruch: Signatur - Datum
Item
End of study: signature date
date
C0807937 (UMLS CUI [1])
Item
End of study: signature - date status
text
C2985875 (UMLS CUI [1])
Studienabbruch: Signatur - Datum Status
Code List
End of study: signature - date status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Item
End of study: signature of investigator
text
C2346576 (UMLS CUI [1])
Studienabbruch: Signatur - Prüfer
Code List
End of study: signature of investigator
CL Item
yes (1)
CL Item
no (0)
Kommentar Studienabbruch
Item
End of study: comment
text
C0947611 (UMLS CUI [1])
Item Group
End of study: violated inclusion/exclusion criteria
C1518546 (UMLS CUI-1)
C1516637 (UMLS CUI-2)
Item
End of study: violated inclusion/exclusion criteria Code
text
C1518546 (UMLS CUI [1,1])
C1516637 (UMLS CUI [1,2])
Studienabbruch: Verletzte Ein-Ausschlusskrit. Code
Code List
End of study: violated inclusion/exclusion criteria Code
CL Item
EIN01 (1)
CL Item
EIN02 (2)
CL Item
EIN03 (3)
CL Item
EIN04 (4)
CL Item
EIN05 (5)
CL Item
EIN06 (6)
CL Item
EIN07 (7)
CL Item
EIN08 (8)
CL Item
EIN09 (9)
CL Item
AUS01 (10)
CL Item
AUS02 (11)
CL Item
AUS03 (12)
CL Item
AUS04 (13)
CL Item
AUS05 (14)
CL Item
AUS06 (15)
CL Item
AUS07 (16)
CL Item
AUS08 (17)
CL Item
AUS09 (18)
CL Item
AUS10 (19)
CL Item
AUS11 (20)
CL Item
AUS12 (21)
CL Item
AUS13 (22)
CL Item
AUS14 (23)
CL Item
AUS15 (24)
Item Group
End of study: adverse event(s)
C1518546 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
Studienabbruch: Unerwünschte(s) Ereignis(se)-AE-Nr
Item
End of study: adverse event(s) Nr
integer
C1518546 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial